Longitudinal studies investigating the development of obesity and T2D have revealed that the signature variables associated with diabetes progression, such as fasting insulin levels, vary significantly across subjects, exhibiting different initiation points, rates of progression, and magnitudes of changes in trajectories [1]. The gene discussed is INS; the disease is type 2 diabetes mellitus.